#ExpertAnswers: Sarah Klein on SignalStar Multiplex IHC (Podcast)

Airdate: Thursday, October 12, 2023 Season: 10 Episode: 24

Guest: Sarah Klein

Dr. Sarah Klein, Associate Director of the Multiplex Assays Group at Cell Signaling Technology, answers questions from a recent webinar about accelerating spatial biology discoveries by 70% using SignalStar™ Multiplex IHC's optimized, ready-to-go panels.

Associated Webinar: Unlocking Spatial Insights: Accelerate Discoveries 70% Faster with SignalStar™ Multiplex IHC

You can listen to this podcast on:

Similar Podcasts

Talking Real Science with Meaghan Loy on Rare Disease Day

On this episode of #ShareScience, we spoke with Meaghan Loy, Senior Category Director of In Vivo Services with Scientist.com, on Rare Disease Day.

#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early

Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses methodologies for predicting drug-drug interactions using in vitro assays and gene expression studies.

#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments

Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.

Related Content

Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials

Join us for a comprehensive webinar featuring experts in epigenetics and assay development, focusing on the scientific foundations and applications of Nucleosome Quantification (Nu.Q®) Technology in the realms of drug development and disease monitoring.

Innovative Approaches to Assessing Thyroid Disruption: The 3D Human Thyroid Microtissue Model

Dr. Chad Deisenroth, PhD, from the US EPA, introduces an advanced human in vitro 3D thyroid microtissue model designed to evaluate thyroid hormone disruption, addressing current challenges with existing models.